The Column Group announced the recruitment of Dr. Eric Olson to the firm’s renowned group of Science Partners. Dr. Olson is the founding Chair of the Department of Molecular Biology at The University of Texas Southwestern Medical Center. He also founded the Center for Regenerative Science and Medicine at UT Southwestern, which is advancing new […]
Dr. Eric Olson joins The Column Group as Science Partner Read More »
The Column Group announces the hiring of Dr. John Josey. Previously, Dr. Josey served as the President, Chief Executive Officer and a member of the Board of Directors of Peloton Therapeutics, from 2013 until its acquisition by Merck in 2019. He joined Peloton in 2011 as the first employee in the role of President and
Dr. John Josey joins The Column Group as Venture Partner Read More »
The Column Group (TCG), a biotech venture capital firm focused on building innovative drug discovery companies, announced the closing of The Column Group IV (TCG IV) and its related investment vehicles totaling $725 million. With TCG IV, the firm will continue to execute on the strategy it has deployed since inception – assembling a focused
The Column Group Raises a $725 Million Fourth Fund Read More »
The Column Group announced the recruitment of Dr. Helen Hobbs to the firm’s renowned group of Science Partners. Dr. Hobbs is Professor of Internal Medicine and Molecular Genetics at the University of Texas Southwestern Medical Center. She is also an investigator at the Howard Hughes Medical Institute.
Dr. Helen Hobbs joins The Column Group as Science Partner Read More »
The Column Group announces the hiring of Dr. Leon Chen. Previously, Dr. Chen was a Venture Partner at Orbimed. Prior to that he was a Partner at Skyline Ventures. Dr. Chen was also a founder of KAI Pharmaceuticals, acquired by Amgen in 2012.
Dr. Leon Chen joins The Column Group as a Partner Read More »
The Column Group announces the promotion of Dr. JJ Kang from Principal to Partner. Dr. Kang has been with TCG since 2015.
Dr. JJ Kang Promoted from Principal to Partner Read More »
The Column Group announced the recruitment of Dr. Vishva Dixit to the firm’s renowned group of Science Partners. Dr. Dixit is Vice President of Physiological Chemistry at Genentech. He is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and a Foreign Member, European
Dr. Vishva Dixit joins The Column Group as Science Partner Read More »
The Column Group announced the recruitment of Dr. Huda Zoghbi and Dr. Charles Zuker to the firm’s renowned group of Science Partners. Dr. Huda Zoghbi is a professor in the Departments of Pediatrics, Molecular and Human Genetics, Neurology and Neuroscience at Baylor College of Medicine. She is also an investigator at the Howard Hughes Medical
Dr. Huda Zoghbi and Dr. Charles Zuker join The Column Group as Science Partners Read More »
The Column Group announces that Dr. Robert Tjian has joined as a Discovery Partner. Dr. Tjian recently served as president of the Howard Hughes Medical Institute from April 2009 through August 2016 and was co-founder of Tularik which was acquired by Amgen in 2004. He is a professor of biochemistry and molecular biology at the
Dr. Robert Tjian joins The Column Group as Discovery Partner Read More »
